NEW YORK (GenomeWeb) – Transgenomic announced today that it has signed an agreement for its ICE-COLD PCR technology with Canadian laboratory services LifeLabs.

Under the terms of the three-year deal, LifeLabs will have a non-exclusive license to the technology and use it in its mutation enrichment platform for cancer testing. The renewable agreement, Transgenomic said, allows LifeLab to benefit from technology improvements and additional product launches during its term.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Mar
13

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.